Vanguard Personalized Indexing Management LLC grew its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 19.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,531 shares of the semiconductor company’s stock after acquiring an additional 3,770 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Synopsys were worth $12,066,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of SNPS. Brighton Jones LLC grew its position in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after buying an additional 50 shares during the period. GAMMA Investing LLC grew its position in shares of Synopsys by 26.8% during the 1st quarter. GAMMA Investing LLC now owns 2,790 shares of the semiconductor company’s stock worth $1,196,000 after buying an additional 590 shares during the period. Integrated Advisors Network LLC grew its position in shares of Synopsys by 8.0% during the 1st quarter. Integrated Advisors Network LLC now owns 529 shares of the semiconductor company’s stock worth $227,000 after buying an additional 39 shares during the period. Azzad Asset Management Inc. ADV acquired a new stake in shares of Synopsys during the 1st quarter worth approximately $2,116,000. Finally, Stock Yards Bank & Trust Co. grew its position in shares of Synopsys by 52.2% during the 1st quarter. Stock Yards Bank & Trust Co. now owns 2,226 shares of the semiconductor company’s stock worth $955,000 after buying an additional 763 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of SNPS opened at $438.92 on Monday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm’s 50 day moving average price is $544.01 and its two-hundred day moving average price is $510.99. The firm has a market cap of $81.53 billion, a P/E ratio of 34.45, a PEG ratio of 4.84 and a beta of 1.10.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Stifel Nicolaus lowered their price target on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Needham & Company LLC lowered their price target on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. The Goldman Sachs Group decreased their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Mizuho decreased their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Finally, Robert W. Baird restated a “neutral” rating and set a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $575.31.
Get Our Latest Stock Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the transaction, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 30,894 shares of company stock worth $16,760,783. Corporate insiders own 0.62% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.